N. Quenel Tueux

Statistics

Publications

Citations

154

H-Index

Active since

2021

Affiliations

Institut Català d'Oncologia(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Institut Jules Bordet

Institut Bergonié

Texas Oncology

N. Quenel Tueux is an author at Institut Català d'Oncologia specializing in metastatic breast cancer treatment, metastatic her2-positive breast cancer, and her2-positive breast cancer therapy.

Publications per year

2021–2024

Publications

LBA15 Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer

C. Saura Manich, Joyce O’Shaughnessy, Philippe Aftimos et al. · Annals of Oncology · 2021 · 104 citations

Medicine, Oncology, Pharmacology +15

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

Nicholas C. Turner, Cristina Saura, Philippe Aftimos et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

386MO Trastuzumab duocarmazine versus physician's choice therapy in pre-treated HER2-positive metastatic breast cancer: Final results of the phase III TULIP trial

Philippe Aftimos, Nicholas C. Turner, Joyce O’Shaughnessy et al. · Annals of Oncology · 2023 · 18 citations · Full text

Medicine, Oncology, Breast Oncology +16

1–3 of 3